India Uncut
This blog has moved to its own domain. Please visit IndiaUncut.com for the all-new India
Uncut and bookmark it. The new site has much more content and some new sections, and you can read about them here and here. You can subscribe to full RSS feeds of all the sections from here.
This blogspot site will no longer be updated, except in case of emergencies, if the main site suffers a prolonged outage. Thanks - Amit.
Thursday, January 20, 2005
Patently controversial
The New York Times ran an editorial yesterday criticising the Indian government for giving in to pharmaceutical lobbyists, and ratifying the WTO agreement that will put an end to the "copycat industry" of generic drugs. The editorial contends: "For the world's poor, this will be a double hit - cutting off the supply of affordable medicines and removing the generic competition that drives down the cost of brand-name drugs."
The Indian Express, meanwhile, has reactions from the government and the opposition.
The Indian Express, meanwhile, has reactions from the government and the opposition.
